Investment Rating - The report maintains a "Recommended" rating for the company with a target price of 9.2 yuan [2][8]. Core Insights - The company achieved a year-on-year increase of 43.4% in net profit attributable to shareholders, reaching 12.8 billion yuan in Q1 2025. The new business value (NBV) for life insurance increased by 31.5% on a comparable basis [2][4]. - As of the end of Q1 2025, the net assets attributable to shareholders rose by 3.9% to 279.3 billion yuan [2]. - The company's combined ratio (COR) improved significantly, standing at 94.5%, which is better than its peers [2][8]. - Investment-driven growth is a key factor behind the company's strong performance, with investment income increasing by 97 billion yuan year-on-year [2][8]. Financial Performance Summary - Total revenue is projected to grow from 621.972 billion yuan in 2024 to 725.562 billion yuan in 2027, with a compound annual growth rate (CAGR) of approximately 5.7% [4]. - Net profit attributable to shareholders is expected to rise from 42.869 billion yuan in 2024 to 55.081 billion yuan in 2027, reflecting a CAGR of about 11.2% [4]. - Earnings per share (EPS) are forecasted to increase from 0.97 yuan in 2024 to 1.25 yuan in 2027 [4]. - The price-to-earnings (P/E) ratio is projected to decrease from 7.3x in 2024 to 5.7x in 2027, indicating potential undervaluation [4]. Business Segment Performance - The property and casualty insurance segment reported a premium income growth of 3.7% year-on-year, with a notable improvement in underwriting profit [2][8]. - Life insurance's NBV growth is attributed to new business value contributions, with a significant increase in health insurance premiums [2][8]. - The company’s investment strategy has been effective, with a focus on bonds and equities leading to substantial investment income growth [2][8].

中国人保：一季度取得较好投资收益 金十数据4月30日讯，在一季度业绩说明会上，中国人保集团投资部副总经理陈晖艳表示，一季度，中 国人保积极把握资本市场投资机会，取得了较好投资收益。在权益投资方面，公司坚持"成长与价值并 重"的投资风格，在春节前市场低位果断加仓，有效把握市场阶段性和结构性机会，一季度公司权益类 资产实现正收益。在固定收益方面，公司灵活把握债券配置节奏，加大交易力度。在利率低点卖出，在 利率相对高点加大长久期债券买入力度，有效提升债券资产对投资收益的贡献。 （证券时报） ...

Investment Rating - The investment rating for the company is "Buy" [8] Core Views - The company's net profit for Q1 2025 reached RMB 12.849 billion, a year-on-year increase of 43%, aligning with the company's previous profit forecast of a 30% to 50% increase [1] - The new business value (NBV) for life insurance increased by 31.5% year-on-year, indicating strong growth resilience [3] - The combined ratio (COR) for property insurance decreased by 3.4 percentage points to 94.5%, primarily due to a reduction in natural disasters [2] - The company's investment performance improved significantly, with investment income rising by 111% year-on-year [4] Summary by Sections Q1 2025 Performance - The company reported a net profit of RMB 12.849 billion for Q1 2025, a 43% increase year-on-year, driven by substantial growth in both insurance services and investment performance [1] - The NBV for life insurance showed a robust increase of 31.5% year-on-year, despite a 12% decline in new single premium [3] Property Insurance - The COR for property insurance decreased to 94.5%, a reduction of 3.4 percentage points year-on-year, attributed to fewer natural disasters [2] - Property insurance premium income grew steadily, with a year-on-year increase of 3.7% [2] Life Insurance - The life insurance segment's NBV growth was resilient, with a projected growth rate of 22% for 2025 [3] - Life insurance profits increased by 13.9% year-on-year, contributing 35% to the company's net profit [3] Investment Performance - The company's investment income saw a significant increase of 111% year-on-year, reflecting strong returns from equity assets [4] - The estimated return on equity (ROE) for 2025 is projected to be 16% [4] Earnings Forecast and Valuation - The EPS forecasts for 2025, 2026, and 2027 have been adjusted to RMB 1.01, RMB 1.01, and RMB 1.09 respectively [5] - The target price based on DCF valuation has been raised to RMB 8.3 for A-shares and HKD 5.3 for H-shares [5]

Core Insights - China Life Insurance reported a net profit of 12.85 billion yuan for Q1 2025, reflecting a year-on-year increase of 43.4%, aligning with expectations [1] - The combined ratio (COR) improved to 94.5%, down 3.4 percentage points year-on-year, driven by reduced disaster risks and effective cost management [2] - The investment income surged to 12.2 billion yuan, marking a 390% year-on-year increase, indicating strong investment performance [1] Group 1: Financial Performance - The net profit attributable to shareholders reached 12.85 billion yuan, with property and casualty insurance net profit at 11.31 billion yuan, up 92.7% year-on-year [1] - Life and health insurance net profits were 3.65 billion yuan and 2.43 billion yuan, showing a year-on-year change of -4.4% and +59.9% respectively [1] - The total premium income for property and casualty insurance was 180.4 billion yuan, reflecting a year-on-year growth of 3.7% [2] Group 2: Underwriting and Premium Growth - The COR for property and casualty insurance improved significantly, attributed to reduced disaster risks and enhanced expense management [2] - The premium growth was steady, with auto insurance premiums at 71.7 billion yuan and non-auto insurance premiums at 108.7 billion yuan, both showing positive year-on-year growth [2] - There was a notable divergence in growth rates among non-auto insurance segments, with health insurance growing by 6.5% while agricultural insurance declined by 4.1% [2] Group 3: Investment and Asset Management - The company's net assets increased to 279.3 billion yuan, up 3.9% quarter-on-quarter, supported by effective asset-liability matching [3] - The total investment return rate for property and casualty insurance improved to 1.2%, reflecting a year-on-year increase of 0.4 percentage points [3] - The solvency ratios for core and comprehensive solvency were 216.3% and 237.5%, respectively, indicating a strong capital position [3] Group 4: Future Outlook - The company maintains a strong buy recommendation, anticipating continued profit growth driven by improved COR and NBV [4] - Projected net profits for 2025-2027 are 46.5 billion, 49.3 billion, and 51.1 billion yuan, with year-on-year growth rates of 8.4%, 6.0%, and 3.6% respectively [4] - The current closing price corresponds to dynamic P/B ratios of 1.08, 1.01, and 0.95 for 2025-2027 [4]

Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The report highlights significant improvements in both underwriting and investment performance, with net profit from property and casualty insurance nearly doubling year-on-year [1][8] - The company is expected to continue optimizing its business structure and cost management, leading to sustained profitability growth [8] Financial Performance Summary - Total revenue for 2023 is projected at 553,097 million RMB, with a year-on-year growth of 4.4%. This is expected to increase to 621,972 million RMB in 2024, representing a growth of 12.5% [1] - The net profit attributable to shareholders is forecasted to be 22,773 million RMB in 2023, with a significant recovery to 42,869 million RMB in 2024, reflecting an 88.2% increase [1] - The diluted book value per share (BVPS) is expected to rise from 5.48 RMB in 2023 to 6.08 RMB in 2024 [1] Business Segment Performance - In Q1 2025, the company reported a net profit of 12.8 billion RMB, a year-on-year increase of 43.4%. The net profits from property and casualty, life, and health insurance segments were 11.3 billion RMB, 3.7 billion RMB, and 2.4 billion RMB, respectively [8] - The property and casualty insurance segment saw a total premium income of 180.4 billion RMB in Q1 2025, with a year-on-year growth of 3.7% [8] - The comprehensive cost ratio for the property and casualty insurance business improved to 94.5%, a decrease of 3.4 percentage points year-on-year, leading to an underwriting profit of 6.63 billion RMB, up 183% [8] Investment Performance - The company achieved a significant increase in investment income, with total investment returns rising by 56.4% year-on-year in Q1 2025 [8] - The report indicates that the company has been optimizing its asset allocation, increasing its exposure to high-quality equity assets, resulting in a 157.2% year-on-year increase in investment income and fair value changes [8] Valuation Metrics - The current market price is 7.11 RMB, with a projected P/B ratio decreasing from 1.30 in 2023 to 0.88 in 2027 [1] - The expected net profit for 2025 is 51 billion RMB, with a corresponding P/E ratio of 7.33 [1][20]

中国平安保险（集团）股份有限公司（以下简称"中国平安"）一季度实现归属于母公司股东的营运利润 379.07亿元，同比增长2.4%。其寿险及健康险业务新业务价值达128.91亿元，同比增长34.9%。其中， 代理人渠道新业务价值同比增长11.5%，银保渠道新业务价值同比增长170.8%。一季度，中国平安旗下 平安产险实现原保险保费收入851.38亿元，同比增长7.7%；整体综合成本率96.6%，同比优化3.0个百分 点。 同期，中国太平洋保险（集团）股份有限公司（以下简称"中国太保"）旗下太保寿险实现规模保费 1184.22亿元，同比增长11.8%；新业务价值57.78亿元，可比口径下同比增长39.0%。中国太保旗下太保 产险实现收入稳定增长、效益显著提升，取得原保险保费收入631.08亿元，同比增长1.0%。 归母净利润最高增长超四成 业务运营整体平稳 2025年一季度，中国经济起步平稳，延续回升向好态势，A股上市险企业务经营整体平稳。 具体来看，一季度，中国人寿保险股份有限公司（以下简称"中国人寿"）总保费达3544.09亿元，同比 增长5.0%。其中，续期保费为2469.75亿元，同比增长9.7%。该公司 ...

证券代码：601319 证券简称：中国人保 公告编号：临 2025-017 中国人民保险集团股份有限公司 关于修订公司章程的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 本公司于 2025 年 4 月 29 日召开的第五届董事会第九次会议审议 通过了《关于修订集团公司〈公司章程〉的议案》（以下简称"本次 修订"），本次修订的详细情况请见附件《〈中国人民保险集团股份有 限公司章程〉修订情况对比表》。 本次修订还须提交本公司股东会审议通过，并将于获得国家金融 监督管理总局核准后方可生效。 附件：《中国人民保险集团股份有限公司章程》修订情况对比表 中国人民保险集团股份有限公司董事会 2025 年 4 月 29 日 1 | 现行章程条款 | | | | 修订后章程条款 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 第一条 为维护中国人民保险集团股份有限公司（以下简称"公司"）、 | | | | 第一条 为维护中国人民保险集团股份有限公司（以下简称"公 ...

证券代码：601319 证券简称：中国人保 公告编号：2025-019 中国人民保险集团股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 4 月 29 日 (二)股东大会召开的地点：北京市西城区西长安街 88 号中国人保大厦 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 910 | | --- | --- | | 其中：A 股股东人数 | 907 | | 境外上市外资股股东人数（H 股） | 3 | | 2、出席会议的股东所持有表决权的股份总数（股） | 36,286,808,892 | | 其中：A 股股东持有股份总数 | 32,815,533,356 | | 境外上市外资股股东持有股份总数（H 股） | 3,471,275,536 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | ...

经与会监事审议并表决，形成以下会议决议： 证券代码：601319 证券简称：中国人保 公告编号：临 2025-018 中国人民保险集团股份有限公司 第四届监事会第二十九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 中国人民保险集团股份有限公司（以下简称"公司"）第四届监 事会第二十九次会议（以下简称"会议"）的通知和材料于 2025 年 4 月 18 日以书面方式发送全体监事，会议于 2025 年 4 月 18 日至 4 月 29 日以书面传签方式召开。经半数以上监事推举，会议由李慧琼 监事召集。会议的召集、召开符合《中华人民共和国公司法》等相关 法律、行政法规、部门规章和公司章程的规定，会议合法、有效。 表决结果：3 票同意，0 票反对，0 票弃权 四、 审议通过了《关于 2025 年 A 股和 H 股第一季度报告的议案》 监事会认为： （一）公司 2025 年 A 股和 H 股第一季度报告的编制和审核程序 符合法律、行政法规、部门规章和公司章程的规定。 （二）公司 2025 年 A 股和 H 股第一季度 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完 整性承担法律责任。 本公司第五届董事会第九次会议（以下简称"会议"）的通知和 材料于 2025 年 4 月 10 日以书面方式通知全体董事，会议于 2025 年 4 月 29 日在北京市西城区西长安街 88 号中国人保大厦以现场会议方 式召开。会议应出席董事 12 名，现场出席 10 名，视频连线出席 2 名。 独立董事徐丽娜、高平阳以视频连线方式出席会议。会议由丁向群董 事长主持。监事会成员及部分高级管理层成员列席了会议。会议的召 开符合《中华人民共和国公司法》等相关法律、行政法规、部门规章 和《中国人民保险集团股份有限公司章程》的规定，会议合法、有效。 经与会董事审议并表决，形成以下会议决议： 一、审议通过了《关于修订集团公司〈公司章程〉的议案》，并 同意提交股东会审议 证券代码：601319 证券简称： 中国人保 公告编号：临 2025-016 中国人民保险集团股份有限公司 第五届董事会第九次会议决议公告 表决结果：12 票同意，0 票反对，0 票弃权 二、审议通过了《关于修订集团公司〈股东 ...